Abstract:Recently, more and more evidence shows that lipid metabolism disorder has been observed in tumor, which impacts tumor cell proliferation, survival, invasion, metastasis, and response to the tumor microenvironment (TME) and tumor treatment. However, hitherto there has not been sufficient research to demonstrate the role of lipid metabolism in pancreatic cancer. This study contrives to get an insight into the relationship between the characteristics of lipid metabolism and pancreatic cancer. We collected samples of patients with pancreatic cancer from the Gene Expression Omnibus (GEO), the Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and the International Cancer Genome Consortium (ICGC) databases. Firstly, we implemented univariate regression analysis to get prognosis-related lipid metabolism genes screened and a construction of protein-protein interaction (PPI) network ensued. Then, contingent on our screening results, we explored the molecular subtypes mediated by lipid metabolism-related genes and the correlated TME cell infiltration. Additionally, we studied the disparately expressed genes among disparate lipid metabolism subtypes and established a scoring model of lipid metabolism-related characteristics using the least absolute shrinkage and selection operator (LASSO) regression analysis. At last, we explored the relationship between the scoring model and disease prognosis, tumor stage, tumor microenvironment, and immunotherapy. Two subtypes, C1 and C2, were identified, and lipid metabolism-related genes were studied. The result indicated that the patients with subtype C2 have a significantly lower survival rate than that of the patients with subtype C1, and we found difference in abundance of different immune-infiltrating cells. The gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses revealed the association of these differentially expressed genes with functions and pathways related to lipid metabolism. Finally, we established a scoring model of lipid metabolism-related characteristics based on the disparately expressed genes. The results show that our scoring model have a substantial effect on forecasting the prognosis of patients with pancreatic cancer. The lipid metabolism model is an important biomarker of pancreatic cancer. Using the model, the relationship between disease prognosis, molecular subtypes, TME cell infiltration characteristics, and immunotherapy in pancreatic cancer patients could be explored.

Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma

Integrated Bioinformatics Analysis Identified COL11A1 As an Immune Infiltrates Correlated Prognosticator in Pancreatic Adenocarcinoma

Lipid Metabolism-Related Gene Markers Used for Prediction Prognosis, Immune Microenvironment, and Tumor Stage of Pancreatic Cancer

Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis

Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer

Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma patients

Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma

Single-Cell RNA Sequencing Analysis Reveals Metabolic Changes in Epithelial Glycosphingolipids and Establishes a Prognostic Risk Model for Pancreatic Cancer

Identification of Basement Membrane-Related Signatures for Estimating Prognosis, Immune Infiltration Landscape and Drug Candidates in Pancreatic Adenocarcinoma.

A Metabolism-Relevant Signature As a Predictor for Prognosis and Therapeutic Response in Pancreatic Cancer.

Identification of Novel Candidate Biomarkers and Efficacious Small Molecule Drugs for Pancreatic Adenocarcinoma Based on Comprehensive Bioinformatics Technology

Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma

Identification of a Robust Functional Subpathway Signature for Pancreatic Ductal Adenocarcinoma by Comprehensive and Integrated Analyses

Development and validation of a four‐lipid metabolism gene signature for diagnosis of pancreatic cancer

Bioinformatics-Based Identification of Tumor Immune Invasion- Related prognostic Biomarkers in pancreatic cancer

Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer

KLK10/LIPH/PARD6B/SLC52A3 Are Promising Molecular Biomarkers for the Prognosis of Pancreatic Cancer Through a Cerna Network

Identification of Novel Candidate Biomarkers for Pancreatic Adenocarcinoma Based on TCGA Cohort

Characterizing adipocytokine-related signatures for prognosis prediction in prostate cancer